Discovery Tightened In FTC's AbbVie Pay-For-Delay Suit
A Pennsylvania federal judge limited discovery Thursday to the sham litigation alleged in the first count of the Federal Trade Commission's suit against AbbVie Inc., which is accused of keeping Teva...To view the full article, register now.
Already a subscriber? Click here to view full article